Nucleic Acid Isolation and Purification Market Size and Advancements 2024 – 2034

The global nucleic acid isolation and purification market was valued at approximately USD 6.1 billion in 2023 and is expected to reach USD 16.65 billion by 2034, reflecting a compound annual growth rate (CAGR) of 9.56% from 2024 to 2034. The increasing adoption of DNA sequencing in clinical diagnostics is a key factor propelling market growth.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5200

Major Key Insights of the Nucleic Acid Isolation and Purification Market

• By region, North America dominated the market by 39.70% share in 2023.
• By region, Asia Pacific is expected to grow at the fastest rate during the forecast period.
• By region, Europe to hold the second largest revenue of USD 1.86 billion in 2023.
• By product, the kits & reagents segment held the largest market share in 2023.
• By type, the DNA isolation and purification segment dominated the market in 2023.
• By application, the diagnostic segment held the largest nucleic acid isolation and purification market share in 2023.
• By method, the magnetic beads segment dominated the market in 2023.
• By end-use, the hospitals & diagnostics centers held the dominant share of the market in 2023.
• By end-use, the pharmaceutical & biotechnology companies segment is expected to grow at the fastest rate during the forecast period.

Top Companies in the Nucleic Acid Isolation and Purification Market

• QIAGEN
• New England Biolabs (NEB)
• LGC Biosearch Technologies
• Promega Corporation
• Alpha Laboratories
• Takara Bio Inc.
• Agilent Technologies
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Merck KGaA
• Danaher
• Bio-Rad Laboratories, Inc.

Innovations in the Nucleic Acid Isolation and Purification Market

New England Biolabs (NEB)

• Headquarters: Massachusetts, U.S., North America
• Recent Development: In April 2024, NEB announced the launch of the Monarch Mag Viral DNA/RNA Extraction Kit. This kit enhances the recovery of small quantities of viral nucleic acids, allowing for extremely sensitive detection. Utilizing a magnetic bead-based method, it effectively extracts viral RNA and DNA, supporting high-throughput automation. The kit is designed for popular sample types, including saliva, respiratory swabs, and wastewater, following an enrichment step.

Alpha Laboratories

• Headquarters: Eastleigh, United Kingdom, Europe
• Recent Development: In January 2024, Alpha Laboratories introduced SmartLid™, an innovative magnetic key and lid system developed in collaboration with ProtonDx. This system simplifies the nucleic acid extraction process and offers a more intelligent approach to handling nucleic acids in molecular biology applications. SmartLid enables quick and efficient viral DNA/RNA extraction by streamlining the critical phases of sample extraction—lysis, wash, and elution. This advancement provides researchers with a practical and environmentally friendly solution for nucleic acid extraction.

Next-Generation Sequencing (NGS) Impact on the Market

Recent advancements in next-generation sequencing (NGS) technology have transformed the nucleic acid isolation and purification market. NGS allows for rapid sequencing of genomes or portions of genomes within days or hours at a lower cost and with high depth. The sequence variants and mutations identified through NGS are increasingly used for prognosis, treatment selection, and patient follow-up, in addition to disease diagnosis. Its massively parallel sequencing capabilities are paving the way for advancements in personalized precision medicine.

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/nucleic-acid-isolation-and-purification-market-sizing

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5200

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare